Chapter 12

Advanced Treatment Techniques In

Radiotherapy

Ayse Gulbin Kavak1

Abstract
Radiotherapy is used to destroy cancer cells or control their growth. The
main purpose of radiotherapy is to protect healthy organs while destroying
the tumor. Ionization radiations such as x-rays, gamma rays and proton
particles are used in radiation therapy. Nowadays, advanced treatment
techniques are used when applying radiotherapy to cancer patients. Advanced
treatment techniques have been developed to target cancer cells and protect
healthy tissues, increase the effectiveness of radiotherapy and minimize side
effects. Treatment techniques applied in radiotherapy largely depend on the
development of technology. With the developments in computer technology,
imaging methods have improved, and parallel to these, there have been
developments in radiotherapy techniques. There are many advanced
treatment techniques used in radiation therapy. The main ones are intensity-
modulated radiation therapy, image-guided radiation therapy, stereotactic
radiosurgery and stereotactic body radiation therapy, adaptive radiotherapy,
brachytherapy, hypofractionation and proton therapy. Intensity modulated
radiation therapy (IMRT ) is a treatment technique that uses different
beams of light to the targeted volume, destroying cancer cells while sparing
surrounding tissues. Image guided radiation therapy (IGRT) uses real-time
image guidance during treatment. Patient position and tumor movements
are observed so that the target can be treated more accurately. Stereotactic
Radiosurgery and Stereotactic Body Radiotherapy are basically based on
treating small lesions by focusing on them with very high doses of radiation.
Adaptive radiotherapy is a radiotherapy technique that takes into account
the patient’s anatomical and physiological changes during cancer treatment.
This technique makes it possible to update the radiotherapy plan in response
to changes in the patient’s body and to provide a treatment that targets the
radiation dose more precisely. Brachytherapy is a treatment technique that

1 Assistant Professor, Gaziantep University, Medical Faculty, Radiation Oncology Department,

kavakgulbin@[Link], [Link]

[Link]
153
154 | Advanced Treatment Techniques in Radiotherapy

involves placing radioactive sources directly or very closely into or near cancer
cells. Hypofractionation involves giving higher doses to the patient in a
shorter period of time compared to conventional radiotherapy fractionation.
Proton therapy is a treatment that targets cancer cells using proton-charged
particles instead of x-rays or gamma rays. Advanced treatment techniques in
radiotherapy offer more options and higher success rates in cancer treatment.
However, the type of cancer for each disease differs from each other, so it is
very important to determine the most appropriate treatment approach for
the patient.

Radiotherapy
Radiotherapy is a medical procedure used in the treatment of cancer.
The goal of radiotherapy is to use high-energy radiation to eradicate cancer
cells or control their growth. While targeting cancer cells for destruction,
radiotherapy aims to minimize damage to the surrounding healthy tissues.
The objectives of radiotherapy can be listed as follows: to destroy cancer
cells or control their growth, reduce the tumor size, alleviate or eliminate
cancer symptoms (Jaffray et al., 2007)
Radiation therapy is divided into external radiotherapy and internal
radiotherapy:
In external radiotherapy, high-energy X-rays are applied from the outside
to the tumoral area. High-energy radiation beams are generated by a machine
for external radiotherapy and directed externally at the patient’s body to
target and treat cancerous cells or tumors (Jaffray et al., 2007).
In internal radiotherapy which is called brachytherapy , the radiation
source is placed directly inside the tumor or body cavities (Ragde, 2004).
The process of radiotherapy starts with imaging. Firstly, a Computed
Tomography (CT) images of the patient are obtained in DICOM format.
The CT image is then transferred to the treatment planning system. The
images transferred to the treatment planning system are fused with magnetic
resonance imaging (MRI) and/or positron emission tomography (PET)
images to contour the target volume. Precise planning is essential for the
effectiveness and safety of radiotherapy. In treatment planning, the aim is
to deliver the desired dose to the tumor while protecting the surrounding
healthy organs. The radiation dose and treatment duration to be administered
to the patient are determined based on the type of cancer and the stage of
the disease. Patient treatment planning in radiotherapy is done by selecting
the appropriate device, energy, and treatment techniques for the tumor. The
most current treatment techniques applied to patients are described in detail
below (Schneider et al., 1996).
 Ayse Gulbin Kavak | 155

1. Intensity Modulated Radiation Therapy (IMRT)

Intensity-Modulated Radiation Therapy (IMRT) is one of the significant
developments in the field of radiation oncology. IMRT aims to deliver
radiation to the tumor with precision, minimizing damage to the surrounding
healthy tissues. One of the primary goals of radiation therapy is to minimize
the damage to healthy tissues while delivering a therapeutic dose of radiation
to the tumor. IMRT represents a paradigm shift in radiation oncology
treatment, allowing different dose distributions to different target volumes.
The origins of IMRT can be traced back to three-dimensional conformal
radiation therapy, which aimed to improve the accuracy of radiation delivery
(Ezzell et al., 2003). While the concept of modulating radiation intensity
was proposed in the 1980s, it was the development of computer technology
and advanced treatment planning systems that made clinical IMRT possible.
The first clinical IMRT treatments began in the early 1990s and marked a
significant milestone in radiation therapy (Jaffray et al., 2007).
IMRT is based on inverse treatment planning, where the desired dose
distribution is determined, and the treatment planning system calculates the
optimal intensity pattern for each beam to achieve this distribution. This
approach is in contrast to conventional radiation therapy, which relies on
forward planning (Jaffray et al., 2007).
IMRT divides each treatment field into multiple beams, each with
different intensities. By modulating these beams according to intensity, an
optimal dose distribution is achieved that conforms to the shape of the tumor.
The accuracy of the dose delivered to the patient is just as important as the
planning of IMRT. When planning in IMRT, a reverse optimization plan is
made by entering the objectives and priority values for the target volume
and critical organs into the system. Additionally, an IMRT plan can be made
by using the multicriteria optimization algorithm found in some treatment
planning systems. (Kavak et al. 2022). Multileaf collimators (MLCs) are
lead plates composed of a series of thin leaves located inside the treatment
device head. IMRT heavily relies on MLCs, which can shape the radiation
field during treatment. This technology allows precise and rapid modulation
of radiation intensity, enhancing dose conformity. With the development
of MLCs, Volumetric Modulated Arc Therapy (VMAT) has also become
applicable. It is a more advanced treatment technique than IMRT. VMAT
treatments can be delivered accurately and effectively with single or multiple
arcs. In Volumetric Modulated Arc Therapy, unlike IMRT, VMAT delivery
is more complex than IMRT because the gantry rotation speed, dose rate
and MLC shape are constantly changing at the same time. The primary
156 | Advanced Treatment Techniques in Radiotherapy

advantage of Volumetric Modulated Arc Therapy is that it can treat the

patient much faster than fixed gantry IMRT. (Surucu et al., 2012). Before
starting IMRT, a patient-specific quality control test is required. Once these
quality control tests meet the eligibility criteria, IMRT or VMAT treatment
can be approved. IMRT is generally applied to cancer types such as head and
neck cancer, prostate cancer, and brain tumors, among others. IMRT is one
of the methods that maximize therapeutic effect in cancer treatment (Jaffray
et al., 2007).

2. Image-Guided Radiation Therapy

Image-Guided Radiation Therapy (IGRT) represents a revolutionary
approach in the implementation of radiation therapy, offering a dynamic and
adaptable approach to cancer treatment. IGRT is a significant advancement
in the field of radiation oncology and plays a central role in providing precise
and personalized radiation therapy while minimizing the impact on healthy
tissues (Xing et al., 2006).
The roots of IGRT may date back to the 1990s when it emerged as an
extension of traditional radiation therapy. The development of IGRT has
progressed in parallel with advances in medical imaging that enable the
integration of real-time imaging and treatment delivery (Simpson et al.,
2010).
The fundamental principle of IGRT is precise target localization.
IGRT ensures that the tumor or target volume is accurately positioned
and monitored in real-time during radiation delivery, not only during the
treatment planning phase. This allows for adjustments to be made based on
the target’s position, shape, and size at any given moment. IGRT enables
adaptable treatment planning that can accommodate changes in the patient’s
anatomy or tumor response during treatment, making it particularly valuable
in managing anatomical changes caused by factors such as weight loss, tumor
regression, or organ motion (Bissonnette et al., 2012).
With technological advancements, IGRT makes use of various imaging
techniques such as cone-beam computed tomography (CBCT), positron
emission tomography (PET), magnetic resonance imaging (MRI), and
ultrasound (Simpson et al., 2010).
IGRT has a wide range of applications in clinical practice for various
cancer types, including prostate cancer, lung cancer, head and neck cancer,
gynecological cancers, brain tumors, and pediatric tumors (Perkins et
al., 2006). The ability to precisely target tumors in IGRT enhances the
effectiveness of this treatment method. Ensuring the accuracy and safety
 Ayse Gulbin Kavak | 157

of IGRT is crucial. Regular equipment calibration, image registration, and

staff training are essential. Quality assurance measures are also important for
minimizing errors and ensuring patient safety. IGRT enables personalized
treatment plans, advanced patient comfort, and convenience (Bissonnette
et al., 2012).

3. Stereotactic Radiosurgery (SRS) and Stereotactic Body

Radiation Therapy (SBRT)
Stereotactic radiosurgery (SRS) is a radiation therapy used to treat
functional abnormalities and small tumors in the brain. In SRS treatment,
a higher dose of radiation is applied in fewer fractions compared to
conventional treatment, which helps better preserve healthy tissue (Combs
et al., 2005). When used to treat body tumors, it is referred to as stereotactic
body radiation therapy (SBRT) (Okunieff et al., 2006). SRS and SBRT
can be considered groundbreaking treatment methods in radiation oncology.
These concepts emerged in the early 20th century with the development of
stereotactic frames for brain surgery (Combs et al., 2005). However, their
application in radiation therapy began in the 1980s and has rapidly advanced
since then. Technological advancements and clinical evidence have facilitated
their adoption.
The main principles of SRS and SBRT are high precision and conformity
(Schefter et al., 2005). They deliver high doses of radiation to the target with
sub-millimeter accuracy while minimizing exposure to surrounding healthy
tissues. This is achieved through the best targeting and immobilization
techniques of the tumor. In SRS, a typical treatment involves delivering a
single high dose in a single session, while the SBRT concept allows for the
treatment of larger and more irregularly shaped tumors by extending it to
several or more fractions (Vergalasova et al., 2019).
SRS and SBRT heavily rely on advanced imaging methods such as Cone
Beam Computed Tomography (CBCT), Magnetic Resonance Imaging
(MRI), and Positron Emission Tomography (PET) for real-time guidance
in treatment planning and delivery.
SRS and SBRT are applied to conditions such as brain metastases,
primary brain tumors, lung cancer, spine and bone metastases, liver tumors,
and prostate cancers. Precise dose optimization algorithms are used for SRS
and SBRT to ensure the target receives a therapeutic dose while minimizing
normal tissue toxicity (Samlowski et al., 2007). Robust quality assurance
measures, including device calibration, image registration, and personnel
training, are necessary to guarantee the safety and accuracy of SRS and
158 | Advanced Treatment Techniques in Radiotherapy

SBRT treatments. Studies have shown high local control rates, reduced side
effects, improved quality of life, and increased survival rates with SRS and
SBRT. With ongoing technological advancements and expanding clinical
indications, SRS and SBRT will continue to play an increasingly prominent
role in modern oncology (Okunieff et al., 2006).

4. Adaptive Radiation Therapy

In the constantly evolving field of radiation oncology, Adaptive Radiation
Therapy (ART) has emerged as a significant advancement. ART represents
a dynamic, patient-centric approach to cancer treatment that harnesses the
power of precise medicine and technology to minimize potential harm
while maximizing therapeutic efficacy. It is an innovative approach to
delivering radiation therapy to cancer patients. Traditional radiation therapy
methods often rely on a one-dimensional approach where treatment plans
are designed based on initial imaging and clinical evaluations (Sonke et al.,
2019). However, tumors are not static and can change in size, shape, and
location during the course of treatment. This variability poses a significant
challenge in ensuring that the intended radiation therapy reaches its target
while sparing healthy tissues (Sonke et al., 2019).
ART is designed to address this challenge by adapting the radiation
treatment plan to these changes. It integrates advanced imaging techniques
like Magnetic Resonance Imaging (MRI) or Positron Emission Tomography
(PET) into the radiation therapy process. In ART, continuous monitoring of
the tumor’s response to treatment and real-time adjustments when needed
are essential. ART often utilizes intensity-modulated radiation therapy
(IMRT) or volumetric modulated arc therapy (VMAT) to further customize
the radiation dose distribution (Aydogan et al., 2011). ART’s versatility
allows for the implementation of various plans in cancer treatment (Castelli
et al., 2018).
One of the key applications of ART is monitoring tumor regression
and adapting to it. As radiation therapy progresses, tumors can shrink or
change shape. By acquiring new patient images, treatment plans are adjusted
to ensure that the tumor remains within the radiation field, allowing the
therapeutic dose to be delivered to the tumor while minimizing damage
to surrounding healthy tissues (Roth et al., 2020). Conversely, for tumors
exhibiting growth or changes in size, ART is necessary to continue treatment.
Detecting these changes early allows for the readjustment of the treatment
plan to encompass the tumor volume and prevent low doses within the
tumor.
 Ayse Gulbin Kavak | 159

Another critical aspect of ART is its ability to protect at-risk organs.

Continuous monitoring allows for adjustments to the treatment plan when
critical structures near the tumor are at risk of receiving excessive radiation.
This feature improves the protection of critical organs like the spinal cord,
brainstem, heart, and lungs when they are in close proximity to the tumor
(Sonke et al., 2019).
ART also helps optimize fractionation schedules. In some cases, treatment
may need adjustments based on the tumor’s response. For instance, if a
tumor responds well to radiation therapy, the treatment plan can be adjusted
to shorten the treatment duration, thereby reducing the patient’s overall
radiation exposure. ART is one way to minimize the risk of complications
arising from re-irradiation for patients who have previously undergone
radiation therapy and require retreatment. By avoiding previously irradiated
areas, the treatment plan can be precisely adapted to enhance the feasibility
of re-treatment (Keall et al., n.d.).
Due to the dynamic nature of ART, it provides increased treatment
accuracy and effectiveness by aligning with changes in tumor position and
size. It minimizes exposure of healthy tissues to radiation, thereby reducing
treatment-related side effects and improving the patient’s quality of life.
The dynamic nature of ART can be attributed to better tumor control and
increased likelihood of successful treatment outcomes (Keall et al., n.d.).
While ART represents a revolutionary approach, it comes with its
challenges and considerations. Implementing ART requires a skilled technical
team and technical expertise. The application of ART relies on advanced
imaging and specialized treatment planning techniques. Continuous
monitoring and plan adaptation can be time-consuming in terms of both
time and equipment. ART is not suitable for every patient and cancer type,
as its application depends on individual circumstances and the feasibility
of real-time adaptation. To effectively harness the full potential of ART,
ongoing research and education are essential. As technology continues to
advance, ART will become even more precise and widely accessible. Artificial
intelligence and machine learning are likely to play a significant role in
automating and facilitating the adaptation process. The future of ART holds
promises for further improving cancer treatment outcomes, reducing side
effects, and enhancing the patient experience.
In conclusion, ART represents a monumental shift in the approach to
cancer treatment. By acknowledging the dynamic nature of tumors, it adapts
treatment plans accordingly. With numerous benefits such as increased
160 | Advanced Treatment Techniques in Radiotherapy

precision, reduced side effects, and improved tumor control, ART is at the
forefront of modern radiation oncology (Keall et al., n.d.).

5. BRACHYTHERAPY
Brachytherapy, commonly referred to as “internal radiation therapy,” is
a highly effective and localized approach in the treatment of various cancer
types. This treatment technique involves the direct placement of sealed
radioactive sources into or near the tumor, allowing for precise radiation
delivery while minimizing exposure to surrounding healthy tissues.
Brachytherapy has a rich history that spans over a century, with its roots
tracing back to the pioneering work of early physicists like Pierre and Marie
Curie, who discovered radioactive elements radium and polonium (Chargari
et al., 2019). These discoveries laid the foundation for the development of
brachytherapy techniques, with the first clinical applications reported in the
early 20th century. Since then, significant advancements have been made in
brachytherapy (Chargari et al., 2019).
Brachytherapy is a treatment technique that utilizes various radioactive
sources. The selection of appropriate sources depends on the type, size, and
location of the tumor. Precise dosimetry is crucial in brachytherapy to ensure
the safe and effective delivery of radiation. The application of brachytherapy
involves special equipment and procedures, including applicators, catheters,
and after loaders (Nag et al., 2000).
Brachytherapy is categorized as interstitial, intracavitary, and surface
brachytherapy. Interstitial brachytherapy involves the direct placement
of radioactive sources into or near the tumor. Examples include prostate
implants and breast cancer. Intracavitary brachytherapy entails the placement
of radioactive sources into natural body cavities such as the cervix or
esophagus. Surface brachytherapy is used to treat skin cancers and other
superficial lesions (Ragde, 2004).
Brachytherapy plays a significant role in the treatment of gynecological
cancers, including cervical, uterine, and vaginal cancers. It can also be
considered as an alternative method for delivering radiation to the entire
breast in breast cancer patients. Over the years, brachytherapy has evolved
into a precise, effective, and well-tolerated cancer treatment method. Ongoing
research and technological innovations continue to offer hope, promising
better outcomes and quality of life for cancer patients. The potential for
brachytherapy to play a more important role in cancer treatment in the
future is both exciting and promising (Chargari et al., 2019).
 Ayse Gulbin Kavak | 161

6. Hypofractionation
Radiation therapy has become the cornerstone of cancer treatment, applied
before or after surgery, in conjunction with chemotherapy. Radiation therapy
provides an effective tool to target and destroy cancer cells. Conventional
radiation therapy programs typically involve giving conventional doses of
radiation therapy 5 days per week. However, the scope of radiation therapy is
evolving and a new approach called hypofractionation is gaining importance
(Jones et al., 2000).
Hypofractionation is a departure from traditional radiation therapy
techniques. Hypofractionation involves giving larger doses of radiation
in fewer treatment sessions, rather than giving smaller doses of radiation
over a long period of time. This approach offers several advantages for both
patients. The most important of these is the shortening of treatment time in
terms of patient comfort. With traditional radiation therapy, patients often
need to visit the treatment center for several weeks; This can be financially
and spiritually difficult and disrupt their daily lives (Jones et al., 2000).
Hypofractionation, on the other hand, allows for a significantly shorter
treatment period. Patients can complete their treatment within a few days
or weeks, reducing the time and effort required for travel and treatment.
Shorter treatment programs mean fewer clinic visits and reduce the financial
burden on both patients and healthcare systems (Hunter et al., 2018).
Hypofractionation is therefore critical in the context of rising healthcare
costs and limited resources. Hypofractionation not only reduces the number
of treatment sessions but also eases transportation difficulties for patients
(Hunter et al., 2018). This is especially helpful for people who live far from
the treatment center. The intensified treatment program of hypofractionation
generally results in fewer side effects and a more comfortable experience for
patients. This can be said to have a positive impact on the overall quality of
life during and after radiation therapy (Jones et al., 2000).
Hypofractionation is a versatile technique that can be applied to various
types of cancer, including breast, prostate, lung and brain cancer. Its
effectiveness is supported by extensive clinical research showing that larger
radiation doses delivered in fewer fractions can provide the same level of
tumor control as conventional fractionation (Hegemann et al., 2014).
Hypofractionation has begun to be used very frequently in breast cancer
treatment. Clinical experience has shown that administering higher doses in
fewer fractions after breast-conserving surgery is not only safe but can also
provide equivalent or even better results compared to conventional radiation
therapy (Hickey et al., 2016).
162 | Advanced Treatment Techniques in Radiotherapy

Hypofractionated radiation therapy has become widely used in the

treatment of prostate cancer. It offers a balance between effective cancer
control and patient convenience. Research shows that this approach can be
as effective as traditional radiation therapy, with the advantage of shorter
treatment time (Hegemann et al., 2014).
Hypofractionation is advantageous for lung and brain cancer patients.
These cancers are often found in areas close to critical organs. Delivering
higher radiation doses in fewer sessions provides better tumor control and
minimizes damage to surrounding healthy tissues (Hegemann et al., 2014).
Although hypofractionation has its benefits, it also has its challenges
and considerations. Careful patient selection, advanced imaging techniques,
and precise treatment planning are crucial to maximize the benefits of this
approach while minimizing the risk of side effects (Haffty, 2010).
In spite of hypofractionation is an exciting development in the field of
radiation therapy, offering patients a shorter and more cost-effective treatment
option, it should be applied with caution due to the high dose delivered.
As technology continues to advance, radiation therapy will become more
precise and personalized, leading to better outcomes for cancer patients.
Hypofractionation represents a significant advance that has the potential
to improve the lives of countless cancer patients worldwide. In the future,
hypofractionation techniques will continue to advance and improve (Jones
et al., 2000).

7. Proton Therapy
In recent years, advances in medical technology have revolutionized the
field of cancer treatment. The most important of these is proton therapy,
a cutting-edge method that offers significant advantages over traditional
radiation therapy. Proton therapy uses protons, positively charged particles,
to target cancer cells with extraordinary precision (Bussière & Adams, 2003).
Proton therapy is a form of radiation therapy that uses charged particles,
protons, to treat cancer. Unlike traditional X-ray or photon therapy, which
uses high-energy photons, proton therapy uses protons that can be precisely
controlled in terms of their speed and energy. This makes it possible to deliver
the radiation dose more accurately, minimizing damage to healthy tissues
and vital organs surrounding the tumor (Sánchez-Parcerisa et al., 2014).
The Particle Acceleration process begins with a particle accelerator, which
produces protons and accelerates them to the desired energy level. Protons
are then directed into the treatment chamber through an array of magnets.
 Ayse Gulbin Kavak | 163

One of the most important advantages of proton therapy is the precise

control of the energy of protons. This allows protons to adjust the range
and depth of penetration into the body, allowing protons to deliver the
maximum radiation dose precisely into the tumor, sparing healthy tissues
(Bussière & Adams, 2003).
Before treatment begins, detailed imaging such as CT scans and MRIs are
used to create a treatment plan that outlines the exact location of the tumor
and the path the protons will take. The medical team creates a treatment plan
to configure the accelerator and magnets for each patient’s unique situation.
After the treatment plan is created, protons are directed to the tumor in a
highly controlled manner. This minimizes radiation exposure to surrounding
healthy tissue and critical structures.
Proton therapy has shown promising results in various types of cancer,
especially in cases where preserving surrounding healthy tissue is crucial.
Some notable applications include:
Pediatric Cancer: Children’s developing bodies are very pediatrically
sensitive to radiation, making proton therapy an excellent option for cancer
cases. It minimizes the risk of long-term side effects and secondary cancer
(Roth et al., 2020).
Brain Tumors: Proton therapy is highly effective in treating brain tumors
because it allows precise targeting near critical structures such as the optic
nerves and brainstem (Skaarup et al., 2021).
Prostate Cancer: Proton therapy has become a popular choice for treating
prostate cancer due to its ability to protect the rectum and bladder from
radiation exposure (Skaarup et al., 2021).
Head and Neck Cancers: Cancers in the head and neck area can be difficult
to treat without damaging important structures such as salivary glands and
vocal cords. Proton therapy reduces secondary damage. It reduces the side
effects of Proton Therapy. Proton therapy minimizes radiation exposure
to healthy tissues, often leading to reduced short-term side effects such
as nausea and skin irritation. Proton therapy is associated with a reduced
risk of long-term complications and improves patients’ quality of life after
treatment. The accuracy of proton therapy results in a higher dose of radiation
being delivered to the tumor, potentially increasing the effectiveness of the
treatment. It may reduce the risk of secondary cancers caused by radiation
therapy because healthy tissues are exposed to less radiation (Skaarup et al.,
2021).
164 | Advanced Treatment Techniques in Radiotherapy

Proton therapy is a remarkable advance in cancer treatment; it offers

better sensitivity and less collateral damage compared to traditional radiation
therapy. As technology continues to advance, it holds great promise for a
broader range of cancer types and patients. The field of proton therapy is
still evolving, and ongoing research and development are expected to further
advance this innovative approach to cancer care (Vanderwaeren et al., 2021).

8. Radiomics and Artificial Intelligence (AI) in Radiation Therapy

Radiation therapy plays a crucial role in treating cancer patients, allowing
precise targeting of tumors while sparing healthy tissues. The integration
of radiomics and artificial intelligence (AI) into radiation therapy has led
to a transformative paradigm shift in the field. Radiomics is an emerging
field in medical imaging that focuses on the extraction of high-dimensional
data from radiological images (Lohmann et al., 2020). These data include
not only standard anatomical information but also textural and quantitative
features that describe the heterogeneity, shape, and spatial distribution
of tumor and healthy tissues. Radiomics can provide a basis for more
precise treatment planning and response assessment by extracting valuable
information normally imperceptible to the human eye. The role of radiomics
in Radiation Therapy is important. Radiomics offers the ability to predict
a tumor’s response to radiation therapy. By analyzing pretreatment imaging
data, radiomics features can provide insights into tumor behavior and help
radiation oncologists tailor treatment plans to the specific characteristics of
the tumor. Radiomics during and after radiation therapy can help evaluate
response to treatment. By measuring changes in tumor tissue and shape over
time, radiomics analysis can provide early indicators of the effectiveness of
treatment or the need for treatment modification (Arimura et al., 2019).
Artificial intelligence, especially machine learning and deep learning, is
beginning to become an important component of radiation therapy. Artificial
intelligence algorithms can aid in treatment planning, decision-making, and
real-time adaptation by processing and analyzing large amounts of radiomics
data (Fu et al., 2022). AI algorithms can optimize radiation treatment
plans by considering radiomics data to determine ideal beam angles, dose
distribution, and fractionation schedules. This leads to more effective tumor
control and reduced damage to surrounding healthy tissues. The automation
of contouring and segmentation tasks in radiation therapy has been greatly
improved thanks to artificial intelligence. Significantly reduces the time and
variability associated with manual identification of structures, increasing
efficiency and consistency in the treatment planning process. AI-powered
adaptive radiation therapy allows real-time adaptation of treatment plans
 Ayse Gulbin Kavak | 165

based on daily imaging. This ensures that treatment remains accurate even
if there are anatomical changes in the patient between sessions (Lohmann
et al., 2020).
Although radiomics and artificial intelligence have great potential in
radiation therapy, they present some challenges. In artificial intelligence, data
quality and standardization are important. High-quality and standardized
imaging data is required for radiomics and AI analyses. Variability in
imaging protocols and equipment can pose challenges to accurate and
reproducible results. Translating radiomics and AI tools from research
to clinical application requires rigorous validation and integration with
existing treatment protocols. Patient data privacy, algorithm transparency,
and regulatory approvals are critical issues that must be addressed as AI
technologies are incorporated into clinical practice (Fu et al., 2022).
The synergy between radiomics and artificial intelligence in radiation
therapy is an evolving field with ongoing research and development. In the
future, AI may be able to provide personalized treatment planning based
on radiomics and genomic data. It can perform patient-specific treatment
adaptation using real-time imaging and artificial intelligence. It may integrate
with other methods, such as genomics, for a comprehensive understanding
of cancer behavior (Arabi & Zaidi, 2020).
Ultimately, radiomics and artificial intelligence have the potential to
revolutionize radiation therapy by providing more precise and personalized
treatment options. As technology continues to advance and research
progresses, the integration of these tools into clinical practice will improve
patient outcomes and reinforce the essential role of radiation therapy in
cancer treatment (Huynh et al., 2020).
These advanced treatment techniques in radiotherapy aim to optimize the
balance between tumor control and healthy tissue preservation, reducing side
effects of treatment and improving overall treatment outcomes. The choice
of technique depends on the specific cancer type, stage, location and patient
characteristics and is determined by a multidisciplinary approach including
radiation oncologists, medical physicists and dosimetrists (Lohmann et al.,
2020).
166 | Advanced Treatment Techniques in Radiotherapy

References
Arabi, H., & Zaidi, H. (2020). Applications of artificial intelligence and
deep learning in molecular imaging and radiotherapy. In European
Journal of Hybrid Imaging (Vol. 4, Issue 1). [Link]
s41824-020-00086-8
Arimura, H., Soufi, M., Kamezawa, H., Ninomiya, K., & Yamada, M. (2019).
Radiomics with artificial intelligence for precision medicine in radiati-
on therapy. Journal of Radiation Research, 60(1), 150–157. [Link]
org/10.1093/jrr/rry077
Aydogan, B., Yeginer, M., Kavak, G. O., Fan, J., Radosevich, J. A., & Gwe-
Ya, K. (2011). Total marrow irradiation with RapidArc volumetric arc
therapy. International Journal of Radiation Oncology Biology Physics, 81(2),
592–599. [Link]
Bissonnette, J. P., Balter, P. A., Dong, L., Langen, K. M., Lovelock, D. M.,
Miften, M., Moseley, D. J., Pouliot, J., Sonke, J. J., & Yoo, S. (2012).
Quality assurance for image-guided radiation therapy utilizing CT-ba-
sed technologies: A report of the AAPM TG-179. Medical Physics, 39(4),
1946–1963. [Link]
Bussière, M. R., & Adams, J. A. (2003). Treatment Planning for Conformal
Proton Radiation Therapy. Technology in Cancer Research and Treatment,
2(5), 389–399. [Link]
Castelli, J., Simon, A., Lafond, C., Perichon, N., Rigaud, B., Chajon, E., De
Bari, B., Ozsahin, M., Bourhis, J., & de Crevoisier, R. (2018). Adaptive
radiotherapy for head and neck cancer. In Acta Oncologica (Vol. 57, Issue
10, pp. 1284–1292). [Link]
Chargari, C., Deutsch, E., Blanchard, P., Gouy, S., Martelli, H., Guérin, F., Du-
mas, I., Bossi, A., Morice, P., Viswanathan, A. N., & Haie-Meder, C.
(2019). Brachytherapy: An overview for clinicians. CA: A Cancer Journal
for Clinicians, 69(5), 386–401. [Link]
Combs, S. E., Widmer, V., Thilmann, C., Hof, H., Debus, J., & Schulz-Ertner,
D. (2005). Stereotactic radiosurgery (SRS): Treatment option for recur-
rent glioblastoma multiforme (GBM). Cancer, 104(10), 2168–2173. ht-
tps://[Link]/10.1002/cncr.21429
Ezzell, G. A., Galvin, J. M., Low, D., Palta, J. R., Rosen, I., Sharpe, M. B., Xia,
P., Xiao, Y., Xing, L., & Yu, C. X. (2003). Guidance document on deli-
very, treatment planning, and clinical implementation of IMRT: Report
of the IMRT subcommittee of the AAPM radiation therapy committee.
Medical Physics, 30(8), 2089–2115. [Link]
Fu, Y., Zhang, H., Morris, E. D., Glide-Hurst, C. K., Pai, S., Traverso, A.,
Wee, L., Hadzic, I., Lonne, P. I., Shen, C., Liu, T., & Yang, X. (2022).
Artificial Intelligence in Radiation Therapy. IEEE Transactions on Radiati-
 Ayse Gulbin Kavak | 167

on and Plasma Medical Sciences, 6(2), 158–181. [Link]

TRPMS.2021.3107454
Haffty, B. G. (2010). Long-term results of hypofractionated radiation therapy
for breast cancer. In Breast Diseases (Vol. 21, Issue 3, pp. 267–268). htt-
ps://[Link]/10.1016/S1043-321X(10)79594-1
Hegemann, N. S., Guckenberger, M., Belka, C., Ganswindt, U., Manapov, F.,
& Li, M. (2014). Hypofractionated radiotherapy for prostate cancer. In
Radiation Oncology (Vol. 9, Issue 1). BioMed Central Ltd. [Link]
org/10.1186/s13014-014-0275-6
Hickey, B. E., James, M. L., Lehman, M., Hider, P. N., Jeffery, M., Francis, D.
P., & See, A. M. (2016). Hypofractionated radiation therapy for early
breast cancer. Cochrane Database of Systematic Reviews, 2017(9). https://
[Link]/10.1002/14651858.cd003860.pub4
Hunter, D., Mauldon, E., & Anderson, N. (2018). Cost-containment in hypof-
ractionated radiation therapy: a literature review. In Journal of Medical
Radiation Sciences (Vol. 65, Issue 2, pp. 148–157). John Wiley and Sons
Ltd. [Link]
Huynh, E., Hosny, A., Guthier, C., Bitterman, D. S., Petit, S. F., Haas-Kogan,
D. A., Kann, B., Aerts, H. J. W. L., & Mak, R. H. (2020). Artificial intelli-
gence in radiation oncology. In Nature Reviews Clinical Oncology (Vol. 17,
Issue 12, pp. 771–781). [Link]
Jaffray, D., Kupelian, P., Djemil, T., & Macklis, R. M. (2007). Review of
image-guided radiation therapy. In Expert Review of Anticancer The-
rapy (Vol. 7, Issue 1, pp. 89–103). Future Drugs Ltd. [Link]
org/10.1586/14737140.7.1.89
Jones, B., Dale, R. G., Finst, P., & Khaksar, S. J. (2000). Biological equivalent
dose assessment of the consequences of hypofractionated radiotherapy.
International Journal of Radiation Oncology Biology Physics, 47(5), 1379–
1384. [Link]
Kavak, A. G., Coşkun, H., & Demiryürek, A. T. (2022). Lokalize prostat kan-
serli hastalarda yoğunluk ayarlı radyoterapi (IMRT) tekniği kullanılarak
standart optimizasyon yöntemi ile çok kriterli optimizasyon (MCO) yön-
teminin karşılaştırılması. European Journal of Science and Technology,
38, 16–23. [Link]
Keall, P., Poulsen, P., oncology, J. B.-S. in radiation, & 2019, undefined. (n.d.).
See, think, and act: real-time adaptive radiotherapy. Elsevier. Retrieved
October 15, 2023, from [Link]
pii/S1053429619300141
Lohmann, P., Bousabarah, K., Hoevels, M., & Treuer, H. (2020). Radiomics
in radiation oncology—basics, methods, and limitations. In Strahlenthe-
rapie und Onkologie (Vol. 196, Issue 10, pp. 848–855). Springer Scien-
168 | Advanced Treatment Techniques in Radiotherapy

ce and Business Media Deutschland GmbH. [Link]

s00066-020-01663-3
Nag, S., Erickson, B., Thomadsen, B., Orton, C., Demanes, J. D., & Petereit,
D. (2000). The American Brachytherapy Society recommendations for
high-dose-rate brachytherapy for carcinoma of the cervix. International
Journal of Radiation Oncology Biology Physics, 48(1), 201–211. [Link]
org/10.1016/S0360-3016(00)00497-1
Okunieff, P., Petersen, A. L., Philip, A., Milano, M. T., Katz, A. W., Boros, L.,
& Schell, M. C. (2006). Stereotactic Body Radiation Therapy (SBRT)
for lung metastases. Acta Oncologica, 45(7), 808–817. [Link]
org/10.1080/02841860600908954
Perkins, C. L., Fox, T., Elder, E., Kooby, D. A., Staley, C. A., & Landry, J.
(2006). Image-guided radiation therapy (IGRT) in gastrointestinal tu-
mors. Journal of the Pancreas, 7(4), 372–381. [Link]
net/profile/David-Kooby-2/publication/6953786_Image-Guided_Radi-
ation_Therapy_IGRT_in_Gastrointestinal_Tumors/links/584e07fc08ae-
4bc899331729/Image-Guided-Radiation-Therapy-IGRT-in-Gastrointes-
[Link]
Ragde, H. (2004). Modern prostate brachytherapy. In Management of Prostate
Cancer: Advances and Controversies (pp. 205–226). CRC Press. https://
[Link]/10.3322/canjclin.50.6.380
Roth, A. K., Ris, M. D., Orobio, J., Xue, J., Mahajan, A., Paulino, A. C., Gros-
shans, D., Okcu, M. F., Chintagumpala, M., & Kahalley, L. S. (2020).
Cognitive mediators of adaptive functioning outcomes in survivors of
pediatric brain tumors treated with proton radiotherapy. Pediatric Blood
and Cancer, 67(2). [Link]
Samlowski, W. E., Watson, G. A., Wang, M., Rao, G., Klimo, P., Boucher, K.,
Shrieve, D. C., & Jensen, R. L. (2007). Multimodality treatment of me-
lanoma brain metastases incorporating stereotactic radiosurgery (SRS).
Wiley Online Library, 109(9), 1855–1862. [Link]
cncr.22605
Sánchez-Parcerisa, D., Kondrla, M., Shaindlin, A., & Carabe, A. (2014). FoCa:
A modular treatment planning system for proton radiotherapy with re-
search and educational purposes. Physics in Medicine and Biology, 59(23),
7341–7360. [Link]
Schefter, T. E., Kavanagh, B. D., Timmerman, R. D., Cardenes, H. R., Baron,
A., & Gaspar, L. E. (2005). A Phase I trial of stereotactic body radiation
therapy (SBRT) for liver metastases. International Journal of Radiation
Oncology Biology Physics, 62(5), 1371–1378. [Link]
ijrobp.2005.01.002
 Ayse Gulbin Kavak | 169

Schneider, U., Pedroni, E., & Lomax, A. (1996). The calibration of CT Houns-
field units for radiotherapy treatment planning. Physics in Medicine and
Biology, 41(1), 111–124. [Link]
Simpson, D. R., Lawson, J. D., Nath, S. K., Rose, B. S., Mundt, A. J., & Mell,
L. K. (2010). A survey of image-guided radiation therapy use in the
United States. Cancer, 116(16), 3953–3960. [Link]
cncr.25129
Skaarup, M., Lundemann, M. J., Darkner, S., Jørgensen, M., Marner, L., Mir-
kovic, D., Grosshans, D., Peeler, C., Mohan, R., Vogelius, I. R., & Ap-
pelt, A. (2021). A framework for voxel-based assessment of biological
effect after proton radiotherapy in pediatric brain cancer patients using
multi-modal imaging. Medical Physics, 48(7), 4110–4121. [Link]
org/10.1002/mp.14989
Sonke, J. J., Aznar, M., & Rasch, C. (2019). Adaptive Radiotherapy for Anato-
mical Changes. In Seminars in Radiation Oncology (Vol. 29, Issue 3, pp.
245–257). [Link]
Surucu, M., Yeginer, M., Kavak, G. O., Fan, J., Radosevich, J. A., & Aydogan,
B. (2012). Verification of dose distribution for volumetric modulated arc
therapy total marrow irradiation in a humanlike phantom. Medical Phys-
ics, 39(1), 281–288. [Link]
Vanderwaeren, L., Dok, R., Verstrepen, K., & Nuyts, S. (2021). Clinical prog-
ress in proton radiotherapy: Biological unknowns. In Cancers (Vol. 13,
Issue 4, pp. 1–16). [Link]
Vergalasova, I., Liu, H., Alonso-Basanta, M., Dong, L., Li, J., Nie, K., Shi, W.,
Teo, B. K. K., Yu, Y., Yue, N. J., Zou, W., & Li, T. (2019). Multi-insti-
tutional dosimetric evaluation of modern day stereotactic radiosurgery
(SRS) treatment options for multiple brain metastases. Frontiers in On-
cology, 9(JUN). [Link]
Xing, L., Thorndyke, B., Schreibmann, E., Yang, Y., Li, T. F., Kim, G. Y., Lux-
ton, G., & Koong, A. (2006). Overview of image-guided radiation
therapy. Medical Dosimetry, 31(2), 91–112. [Link]
meddos.2005.12.004
170 | Advanced Treatment Techniques in Radiotherapy